Dr Leendert Trouw (LUMC)

Elena Goichoechea de Jorge (Madrid, Spain)

Dr Felix Poppelaars (UMCG): Leveraging Complement Genetics to Enhance Long-Term Outcomes in Kidney Transplantation

Christine Yanni (Genmab): The Role of Antibody Formats and Complement in Antigen Delivery to Dendritic Cells

Karla I. de la O Becerra (UU): Insights into classical and lectin pathway C3 convertase

Jolein Gloerich (RadboudUMC): Advancing Diagnostics for Complement-Mediated Diseases: A Mass Spectrometry-Based Approach for Comprehensive Complement Protein Quantitation in Plasma

Tereza Kadavá (UU):Spider Chasing Its Prey: Structural Insights into Human Serum C4b-binding Protein and Its Complexes

Dr Inkeri Lokki (Helsinki, Finland): Complement in pregnancy

Dr Josephine Vos (AUMC): The potential of complement inhibitors; the case of cold agglutinin disease and sutimlimab

Sofie Rutjens (argenx): The story of empasiprubart (ARGX-117) a long acting inhibitory C2 antibody from bench to MMN patients

Haiyu Wang (LUMC): Bispecific antibodies targeting endogenous complement inhibitors for targeted local complement inhibition in the context of rheumatoid arthritis

Caroline Klaver (ErasmusMC): Effect of Pegcetacoplan on Aqueous Humor Proteome in Geographic Atrophy: A Prospective Exploration

Frank Baas (LUMC) : Combatting neuroinflammation by complement inhibition

Juliette van Noort (CHDR) : Intradermal LPS as a human challenge model for pharmacodynamic evaluation of future complement-targeting drugs

Leendert Trouw (LUMC)

Posterviewing session